Upload
PPT-Figure 2 Figure 2. Comparison of GyrA quinolone-resistance–determining region

PPT-Figure 2 Figure 2. Comparison of GyrA quinolone-resistance–determining region

Author : elyana | Published Date : 2023-05-20

Singhal S Purnapatre KP Kalia V Dube S Nair D Deb M et al CiprofloxacinResistant Neisseria meningitidis Delhi India Emerg Infect Dis 2007131016141616 httpsdoiorg103201eid1310060820

gyra qrdr ciprofloxacin sfdj qrdr gyra resistant rrl strains ile amino meningitidis val thr acids neisseria sensitive

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 2 Figure 2. Comparison o..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 2 Figure 2. Comparison of GyrA quinolone-resistance–determining region: Transcript

Singhal S Purnapatre KP Kalia V Dube S Nair D Deb M et al CiprofloxacinResistant Neisseria meningitidis Delhi India Emerg Infect Dis 2007131016141616 httpsdoiorg103201eid1310060820. acaricide resistance and the success of Integrated Pest Management (IPM) techniques in . Apis mellifera . colonies of Virginia. History and Impacts of . Varroa destructor . Originally found in . Apis cerana . Bergin IL, Wise AG, Bolin SR, Mullaney TP, Kiupel M, Maes RK. Novel Calicivirus Identified in Rabbits, Michigan, USA. Emerg Infect Dis. 2009;15(12):1955-1962. https://doi.org/10.3201/eid1512.090839. Bansal V, Metzner KJ, Niederöst B, Leemann C, Böni J, Günthard HF, et al. Minority K65R Variants and Early Failure of Antiretroviral Therapy in HIV-1–infected Eritrean Immigrant. Emerg Infect Dis. 2011;17(10):1966-1968. https://doi.org/10.3201/eid1710.110592. King CH, Muchiri EM, Ouma JH. Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis. 2000;6(6):585-594. https://doi.org/10.3201/eid0606.000606. Currie BJ, Haslem A, Pearson T, Hornstra H, Leadem B, Mayo M, et al. Identification of Melioidosis Outbreak by Multilocus Variable Number Tandem Repeat Analysis. Emerg Infect Dis. 2009;15(2):169-174. https://doi.org/10.3201/eid1502.081036. Fredricks DN, Jolley JA, Lepp PW, Kosek JC, Relman DA. Rhinosporidium seeberi: A Human Pathogen from a Novel Group of Aquatic Protistan Parasites. Emerg Infect Dis. 2000;6(3):273-282. https://doi.org/10.3201/eid0603.000307. Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, et al. Genetic Diversity and Distribution of Peromyscus-Borne Hantaviruses in North America. Emerg Infect Dis. 1999;5(1):75-86. https://doi.org/10.3201/eid0501.990109. Li J, Collins WE, Wirtz RA, Rathore D, Lal A, McCutchan TF. Geographic Subdivision of the Range of the Malaria Parasite, Plasmodium vivax. Emerg Infect Dis. 2001;7(1):35-42. https://doi.org/10.3201/eid0701.700035. Huang SS, Labus BJ, Samuel MC, Wan DT, Reingold AL. Antibiotic Resistance Patterns of Bacterial Isolates from Blood in San Francisco County, California, 1996-1999. Emerg Infect Dis. 2002;8(2):195-201. https://doi.org/10.3201/eid0802.010102. Andraševiæ AT, Tambiæ T, Kaleniæ S, Jankoviæ V. Surveillance for Antimicrobial Resistance in Croatia. Emerg Infect Dis. 2002;8(1):14-18. https://doi.org/10.3201/eid0801.010143. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial Drug Use and Resistance in Europe. Emerg Infect Dis. 2008;14(11):1722-1730. https://doi.org/10.3201/eid1411.070467. Kirschner DE, Webb G. Resistance, Remission, and Qualitative Differences in HIV Chemotherapy. Emerg Infect Dis. 1997;3(3):273-283. https://doi.org/10.3201/eid0303.970303. Salzberg SL, Kingsford C, Cattoli G, Spiro DJ, Janies DA, Aly MM, et al. Genome Analysis Linking Recent European and African Influenza (H5N1) Viruses. Emerg Infect Dis. 2007;13(5):713. https://doi.org/10.3201/eid1305.070013. Shah N, Richardson J, Moodley P, Moodley S, Babaria P, Ramtahal M, et al. Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa. Emerg Infect Dis. 2011;17(3):510-513. https://doi.org/10.3201/eid1703.101363.

Download Document

Here is the link to download the presentation.
"Figure 2 Figure 2. Comparison of GyrA quinolone-resistance–determining region"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Figure 9 Figure 9. Dendrogram constructed for comparison of open reading frame

Figure 9 Figure 9. Dendrogram constructed for comparison of open reading frame
Figure Figure. Kinetics of viremia, CD4+ T-cell count, and drug resistance mutations

Figure Figure. Kinetics of viremia, CD4+ T-cell count, and drug resistance mutations
Figure 4 Figure 4. a. Hardy-Weinberg equilibrium analysis of the increase in

Figure 4 Figure 4. a. Hardy-Weinberg equilibrium analysis of the increase in
Figure 1 Figure 1. Comparison of multilocus sequence typing (MLST) and 4-locus

Figure 1 Figure 1. Comparison of multilocus sequence typing (MLST) and 4-locus
Figure 4 Figure 4. An oligonucleotide probe complementary to a unique region

Figure 4 Figure 4. An oligonucleotide probe complementary to a unique region
Figure 1 Figure 1. Overall hantavirus phylogenetic tree based on analysis of

Figure 1 Figure 1. Overall hantavirus phylogenetic tree based on analysis of
Figure 1 Figure 1. Comparison of the relative developmental success of 11 different

Figure 1 Figure 1. Comparison of the relative developmental success of 11 different
Figure 4 Figure 4. Yearly percent resistance to ciprofloxacin, ceftazidime, imipenem,

Figure 4 Figure 4. Yearly percent resistance to ciprofloxacin, ceftazidime, imipenem,
Figure 3 Figure 3. Resistance rates (%) to selected antimicrobial agents in gram-negative

Figure 3 Figure 3. Resistance rates (%) to selected antimicrobial agents in gram-negative
Figure 2 Figure 2. Proportion of penicillin-nonsusceptible Streptococcus pneumoniae

Figure 2 Figure 2. Proportion of penicillin-nonsusceptible Streptococcus pneumoniae
Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient
Figure 1 Figure 1. Phylogenetic tree of hemagglutinin (HA) segments from 36 avian

Figure 1 Figure 1. Phylogenetic tree of hemagglutinin (HA) segments from 36 avian
Figure 2 Figure 2. Determination of prevalence of tuberculosis (TB) and drug

Figure 2 Figure 2. Determination of prevalence of tuberculosis (TB) and drug